Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation

被引:99
|
作者
Dehne, Tilo [1 ,2 ]
Karlsson, Camilla [3 ]
Ringe, Jochen [1 ,2 ]
Sittinger, Michael [1 ,2 ]
Lindahl, Anders [3 ]
机构
[1] Charite, Tissue Engn Lab, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany
[2] Charite, Dept Rheumatol & Clin Immunol, Berlin Brandenburg Ctr Regenerat Therapies, D-10117 Berlin, Germany
[3] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Lab Med, SE-41345 Gothenburg, Sweden
关键词
HUMAN ARTICULAR CHONDROCYTES; ADULT STEM-CELLS; GENE-EXPRESSION; ENGINEERED CARTILAGE; BONE; PROLIFERATION; DEFECTS; GROWTH; KNEE; METALLOPROTEINASES;
D O I
10.1186/ar2800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Autologous chondrocyte transplantation (ACT) is a routine technique to regenerate focal cartilage lesions. However, patients with osteoarthritis (OA) are lacking an appropriate long-lasting treatment alternative, partly since it is not known if chondrocytes from OA patients have the same chondrogenic differentiation potential as chondrocytes from donors not affected by OA. Methods Articular chondrocytes from patients with OA undergoing total knee replacement (Mankin Score > 3, Ahlback Score > 2) and from patients undergoing ACT, here referred to as normal donors (ND), were isolated applying protocols used for ACT. Their chondrogenic differentiation potential was evaluated both in high-density pellet and scaffold (Hyaff-11) cultures by histological proteoglycan assessment (Bern Score) and immunohistochemistry for collagen types I and II. Chondrocytes cultured in monolayer and scaffolds were subjected to gene expression profiling using genome-wide oligonucleotide microarrays. Expression data were verified by using real-time PCR. Results Chondrocytes from ND and OA donors demonstrated accumulation of comparable amounts of cartilage matrix components, including sulphated proteoglycans and collagen types I and II. The mRNA expression of cartilage markers (ACAN, COL2A1, COMP, CRTL1, SOX9) and genes involved in matrix synthesis (BGN, CILP2, COL9A2, COL11A1, TIMP4) was highly induced in 3D cultures of chondrocytes from both donor groups. Genes associated with hypertrophic or OA cartilage (ALPL, COL1A1, COL3A1, COL10A1, MMP13, POSTN, PTH1R, RUNX2) were not significantly regulated between the two groups of donors. The expression of 661 genes, including COMP, FN1, and SOX9, was differentially regulated between OA and ND chondrocytes cultured in monolayer. During scaffold culture, the differences diminished between the OA and ND chondrocytes, and only 184 genes were differentially regulated. Conclusions Only few genes were differentially expressed between OA and ND chondrocytes in Hyaff-11 culture. The risk of differentiation into hypertrophic cartilage does not seem to be increased for OA chondrocytes. Our findings suggest that the chondrogenic capacity is not significantly affected by OA, and OA chondrocytes fulfill the requirements for matrix-associated ACT.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation
    Tilo Dehne
    Camilla Karlsson
    Jochen Ringe
    Michael Sittinger
    Anders Lindahl
    Arthritis Research & Therapy, 11
  • [2] Keynote: Biomaterials for autologous matrix-associated chondrocyte transplantation
    Marlovits, S.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 53 - 53
  • [3] BONE MORPHOGENETIC PROTEIN-2 IS A SPECIFIC CHONDROGENIC INDUCER WITH POTENTIAL USE FOR (MATRIX-ASSOCIATED) AUTOLOGOUS CHONDROCYTE IMPLANTATION
    Claus, S.
    Aubert-Foucher, E.
    Demoor, M.
    Chajra, H.
    Mayer, N.
    Damour, O.
    Galera, P.
    Mallein-Gerin, F.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S116 - S116
  • [4] Matrix-associated autologous chondrocyte transplantation in a compartmentalized early stage of osteoarthritis
    Schinhan, M.
    Gruber, M.
    Dorotka, R.
    Pilz, M.
    Stelzeneder, D.
    Chiari, C.
    Roessler, N.
    Windhager, R.
    Nehrer, S.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 (01) : 217 - 225
  • [5] Matrix-associated autologous chondrocyte transplantation (MACT). Minimally invasive technique in the knee
    Anders, Sven
    Schaumburger, Jens
    Schubert, Thomas
    Grifka, Joachim
    Behrens, Peter
    OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE, 2008, 20 (03): : 208 - 219
  • [6] Matrix Production Affects MRI Outcomes After Matrix-Associated Autologous Chondrocyte Transplantation in the Knee
    Albrecht, Christian
    Reuter, Carla-Antonia
    Stelzeneder, David
    Zak, Lukas
    Tichy, Brigitte
    Nuernberger, Sylvia
    Boesmueller, Sandra
    Marlovits, Stefan
    Trattnig, Siegfried
    Hajdu, Stefan
    Aldrian, Silke
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2017, 45 (10): : 2238 - 2246
  • [7] Functional Outcome of Matrix-Associated Autologous Chondrocyte Implantation in the Ankle
    Dixon, Sean
    Harvey, Leigh
    Baddour, Edward
    Janes, Greg
    Hardisty, Gerard
    FOOT & ANKLE INTERNATIONAL, 2011, 32 (04) : 368 - 374
  • [8] Gene expression and cell differentiation in matrix-associated chondrocyte transplantation grafts: a comparative study
    Albrecht, C.
    Tichy, B.
    Nuernberger, S.
    Hosiner, S.
    Zak, L.
    Aldrian, S.
    Marlovits, S.
    OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (10) : 1219 - 1227
  • [9] GENE EXPRESSION AND CELL DIFFERENTIATION IN MATRIX-ASSOCIATED CHONDROCYTE TRANSPLANTATION GRAFTS: A COMPARATIVE STUDY
    Albrecht, C.
    Tichy, B.
    Nuernberger, S.
    Hosiner, S.
    Zak, L.
    Aldrian, S.
    Marlovits, S.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2011, 34 (08): : 611 - 611
  • [10] Clinical evaluation after matrix-associated autologous chondrocyte transplantation A COMPARISON OF FOUR DIFFERENT GRAFT TYPES
    Binder, H.
    Hoffman, L.
    Zak, L.
    Tiefenboeck, T.
    Aldrian, S.
    Albrecht, C.
    BONE & JOINT RESEARCH, 2021, 10 (07): : 370 - 379